← Eichor
Study identifier: NCT06409884 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Diagnosing Drug Allergy: the T is the Key

Condition: Amoxicillin Allergy  ·  Sponsor: University Hospital, Antwerp

PhaseNA
Planned participants300
Who can joinAll sexes, 6 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this clinical trial is to validate a newly developed test in the diagnosis of patients with amoxicillin allergy (i.e. T-cell activation test). The main questions the study aims to assess are the reliability and applicability of this test. Participants will be asked to visit the hospital 1, 3 or 5 times during which blood is collected and when applicable, allergy skin testing is performed.

This description comes directly from the study's public registry record.

Talk to the study team

Didier Ebo, PhD  ·  +3238215027  ·  Didier.Ebo@uza.be

Laura Peeters, Msc  ·  Laura.Peeters@uza.be

Always discuss trial participation with your own doctor first.

Locations (1)

Antwerp University HospitalEdegem, Antwerp, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06409884